Literature DB >> 11018029

Distinct oligomeric states of SMAD proteins in the transforming growth factor-beta pathway.

L Jayaraman1, J Massague.   

Abstract

Protein interactions are critical for the function of SMADs as mediators of transforming growth factor-beta (TGF-beta) signals. TGF-beta receptor phosphorylation of SMAD2 or SMAD3 causes their association with SMAD4 and accumulation in the nucleus where the SMAD complex binds cofactors that determine the choice of target genes. We provide evidence that in the basal state, SMADs 2, 3, and 4 form separate, strikingly different complexes. SMAD2 is found mostly as monomer, whereas the closely related SMAD3 exists in multiple oligomeric states. This difference is due to a unique structural element in the MH1 domain of SMAD2 that inhibits protein-protein interactions in the basal state. In contrast to SMAD2 and SMAD3, SMAD4 in the basal state is found mostly as a homo-oligomer, most likely a trimer. Upon cell stimulation with TGF-beta, SMAD proteins become engaged in a multitude of complexes ranging in size from SMAD2-SMAD4 heterodimers to assemblies of >650 kDa. The latter display the highest DNA binding affinity for the TGF-beta-response elements of JUNB and collagen 7. These observations, all validated with endogenous SMAD proteins, modify previous models regarding the assembly and activity of SMAD complexes in the TGF-beta pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018029     DOI: 10.1074/jbc.M005799200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.

Authors:  S L Stroschein; S Bonni; J L Wrana; K Luo
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

2.  An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells.

Authors:  Jay L Vivian; Yijing Chen; Della Yee; Elizabeth Schneider; Terry Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

Review 3.  The role of the endoplasmic reticulum protein calreticulin in mediating TGF-β-stimulated extracellular matrix production in fibrotic disease.

Authors:  Benjamin Y Owusu; Kurt A Zimmerman; Joanne E Murphy-Ullrich
Journal:  J Cell Commun Signal       Date:  2017-10-28       Impact factor: 5.782

4.  Inhibitory RNA molecules in immunotherapy for cancer.

Authors:  Chih-Ping Mao; T-C Wu
Journal:  Methods Mol Biol       Date:  2010

5.  CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling.

Authors:  Zhe Ying; Han Tian; Yun Li; Rong Lian; Wei Li; Shanshan Wu; Hui-Zhong Zhang; Jueheng Wu; Lei Liu; Junwei Song; Hongyu Guan; Junchao Cai; Xun Zhu; Jun Li; Mengfeng Li
Journal:  J Clin Invest       Date:  2017-04-04       Impact factor: 14.808

6.  Nuclear accumulation of Smad complexes occurs only after the midblastula transition in Xenopus.

Authors:  Yasushi Saka; Anja I Hagemann; Olaf Piepenburg; James C Smith
Journal:  Development       Date:  2007-10-24       Impact factor: 6.868

7.  Structure of Smad1 MH1/DNA complex reveals distinctive rearrangements of BMP and TGF-beta effectors.

Authors:  Nithya BabuRajendran; Paaventhan Palasingam; Kamesh Narasimhan; Wenjie Sun; Shyam Prabhakar; Ralf Jauch; Prasanna R Kolatkar
Journal:  Nucleic Acids Res       Date:  2010-02-10       Impact factor: 16.971

8.  Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

Authors:  X Guo; D S Waddell; W Wang; Z Wang; N T Liberati; S Yong; X Liu; X-F Wang
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

9.  Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling.

Authors:  Xing Guo; Alejandro Ramirez; David S Waddell; Zhizhong Li; Xuedong Liu; Xiao-Fan Wang
Journal:  Genes Dev       Date:  2008-01-01       Impact factor: 11.361

10.  Preferential utilization of Imp7/8 in nuclear import of Smads.

Authors:  Xiaohao Yao; Xiaochu Chen; Charisa Cottonham; Lan Xu
Journal:  J Biol Chem       Date:  2008-06-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.